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In assessing the cost-effectiveness of an intervention, the interpretation and handling of uncertainties of the
traditional summary measure, the Incremental Cost Effectiveness Ratio (ICER), can be problematic. This is particularly
the case with strategies towards universal health coverage in which the decision makers are typically concerned
with coverage and equity issues. We explored the feasibility and relative advantages of the net-benefit framework
(NBF) (compared to the more traditional Incremental Cost-Effectiveness Ratio, ICER) in presenting results of
cost-effectiveness analysis of a community based health insurance (CBHI) scheme in Nouna, a rural district of
Burkina Faso. Data were collected from April to December 2007 from Nouna’s longitudinal Demographic
Surveillance System on utilization of health services, membership of the CBHI, covariates, and CBHI costs. The
incremental cost of a 1 increase in utilization of health services by household members of the CBHI was 433,000
XOF ($1000 approximately). The incremental cost varies significantly by covariates. The probability of the CBHI
achieving a 1% increase in utilization of health services, when the ceiling ratio is $1,000, is barely 30% for
households in Nouna villages compared to 90% for households in Nouna town. Compared to the ICER, the NBF
provides more useful information for policy making.
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Economic evaluation in general, and cost-effectiveness
analysis in particular is deemed by scholars, health ad-
ministration and policy experts a centerpiece of the deci-
sion making process by balancing health gains against
costs of interventions [1]. The results of cost effective-
ness analysis provide a rationale to enhance the effi-
ciency of resource allocation. Traditionally, the use of
cost effectiveness analysis as a tool to inform and guide
resources allocation has revolved around the Incremen-
tal Cost Effectiveness Ratio (ICER), which indicates the
additional amount of money needed to obtain an extra
unit of health gain or to prevent an adverse event com-
pared to alternatives. However, apart from few situations
with a clearly dominant intervention (less effective and
more costly or more effective and less costly) compared* Correspondence: hounton_sennen@yahoo.fr
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distribution, and reproduction in any mediumto alternatives, most interventions will present a situ-
ation in which there is a need of a threshold value, a
ceiling that the decision maker is willing to pay as a
good value for money (Figure 1). New interventions in
clinical medicine are likely to be more effective and
more costly because breakthroughs in medical proce-
dures and new technologies are typically more expensive
than existing practices. In these cases, not only is there a
need to estimate the maximum a provider (society, or
the health system for example) is willing to pay for an
additional unit of health gain, but it is also difficult to re-
liably build confidence intervals around the ICER esti-
mates for inferential analysis. The value of the
maximum a provider is willing to pay for an additional
unit of health gain is often estimated through extensive
willingness to pay surveys and is not always available to
the analysts. The use of the net-benefit framework, a re-
cently developed approach and mostly applied in
pharmacoeconomics and clinical interventions [2,3], pre-
sents the potential to overcome the current limitationsed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Cost-effectiveness plane.
80% confidence intervals 
Figure 2 Cost-effectiveness acceptability curves, Nouna CBHI,
Burkina Faso. * Please note on X-axis actual values correspond to
displayed values * 1000.
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imum value a provider is willing to pay to achieve an
extra unit in health gain for the decision rule in public
health [4-8]. The aim of this study was to assess the
feasibility and relative advantages of the net-benefit
framework in assessing the cost-effectiveness of an inter-
vention towards universal health coverage compared to
the traditional ICER approach.
Methods
Context and participants
The Nouna health district, also referred to as Kossi
province, is a rural health district situated in the North
West of Burkina Faso. The area is characterized by dry
weather with a mean annual rainfall of about 800 mm
resulting in dry savannah vegetation. In the early 1990s,
a Demographic Surveillance System (DSS) was estab-
lished by the Nouna Health Research Centre. The ori-
ginal DSS area covered 39 villages (~population about
26 000 inhabitants) and has been progressively extended
to cover 58 villages and Nouna town, with a population
of about 72 000 people. The density of population was
about 35 individuals per square km. The population is
distributed in roughly 9,500 households and composed
of 65% rural dwellers and 35% Nouna semi-urban dwell-
ers. The population is essentially young with children
less than 15 years of age representing about 48% of the
total population, and only 6.2% above 60 years of age.
The inhabitants are mostly subsistence farmers and/or
cattle keepers, and illiteracy is extremely high, over 80%
(Figure 2).The interventions
The Nouna community based health insurance scheme
(CBHI) was launched in 2004 and was developed by the
Nouna Health Research Centre as an operational re-
search project to study how to improve community ac-
cess and uptake of health services and how to meet the
need of the poor within Nouna health district. The inter-
vention has been extensively described in the literature
[9-13]. It is a voluntary community health insurance
scheme which aims to reduce financial barriers (out-of-
pocket payments) and improve quality of care, thus im-
proving access and uptake of health care. The alternative
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CBHI).
Data collection and analysis
Data were extracted from the longitudinal Nouna demo-
graphic and surveillance site on membership of the
Nouna CBHI, utilization of health services, the average
distance from village to health centre, assets ownership,
age and education level of the head of household. In
order to generate household-level costs of the CBHI
scheme from a societal perspective we added, for every
household member of the scheme, the household costs
(enrolment fees and premium) to the average cost of en-
rolling in the Nouna CBHI scheme from the health sys-
tem perspective. The latter was obtained by dividing the
2007 annual costs of running the Nouna CBHI scheme
by the number of households, members (370) in 2007.
For households which are not members of the scheme,
there is obviously no cost incurred for membership fees.
However, these households have to meet the cost of the
utilization of health services out of pocket. We use the
estimated cost of the benefit package of the Nouna
CBHI which was 9630 West Africa francs (XOF),
equivalent to approximately $20) in 2004 [12]. We com-
puted ICER for extra additional utilization of health ser-
vices, and cost effectiveness acceptability curves (CEAC)
to illustrate the decision rule of cost effectiveness of the
intervention.
The ICER decision rule is that if the estimated ICER
lies below the ceiling ratio, which represents the max-
imum decision makers are willing to pay for an incre-
mental unit of the measure of effectiveness, then the
intervention concerned is deemed cost-effective. By
varying the ceiling ratio, the varying probability that the
intervention is cost-effective can be identified. The
CEAC shows the probability of the intervention being
cost-effective for all potential values of the ceiling ratio.
Unlike the ICER approach, the CEAC can also be em-
ployed to obtain a confidence interval of cost-effectiveness.
It also avoids the problems of interpretation of a nega-
tive ICER [14,15]. There isa straightforward graphical
representation and interpretation that a new treatment
is not cost effective [7]. In this paper, the likelihood
values that the Nouna CBHI is cost-effective compared
to the status quo were obtained using the p-values on
the Nouna CBHI dummy when running an Ordinary
Least Square (OLS) regression. The p-values are 2-sided
p-values; however only one-sided probability is needed
to test whether the incremental net-benefit is positive
(Nouna CBHI is preferred) or negative (the status quo is
preferred). The one–sided p-values were thus obtained
by dividing the 2-sided p-values by 2. For negative in-
cremental net-benefits the probabilities that Nouna
CBHI is preferred equals the one sided p-values, andfor positive incremental net-benefits, the probabilities
that the Nouna CBHI is preferred equals 1 minus the
one sided p-values (Hoch JS et al, 2006). A major
strength of this technique when it comes to resource al-
location is that for a given budget, one can model the
different probabilities that the Nouna CBHI is preferred
to the status quo.
However, whilst this technique could be sufficient in
clinical care decisions about the choice of preferred
medication, technology, or screening exam, in the public
health field, a decision maker is often concerned about
issues beyond the optimality of one intervention over
another, especially with issues of equity. This is where
the net-benefit framework could potentially be very use-
ful in assessing the effect of significant determinants on
the marginal cost-effectiveness of a universal health
coverage intervention such as the Nouna community
based health insurance.
Given access to health care is influenced by major
determinants (such as the distance to health facilities,
education, or assets ownership), a net-benefit frame-
work, applied to the cost effectiveness of the Nouna
CBHI, could be effective through the joint probability
distribution in identifying the most important determi-
nants that affect the cost-effectiveness results. The net-
benefit framework employs linear regression techniques,
and to date, has been most often used alongside clinical
trials of health care regimens or technology devices [2-
5]. Thus, it has the potential even for observational stud-
ies with patient-level effect and cost data, for the better
presentation and interpretation of cost-effectiveness
results and better evidence based decision making.
The traditional equation ΔC/ΔE (ICER) can be re-
arranged by multiplying each arm of the equation by ΔE.
The result is ΔC=ΔE * ICER and for any ceiling ratio
Ro, ΔC=ΔE * Ro. Thus, a net-benefit statistic can be
computed as follows: ΔE * Ro−ΔC=ΔNB. We computed
for each observation (household) in the household sur-
vey an individual net-benefit statistic. The expression of
an individual net-benefit NBi =ΔEi * Ro−ΔCi is similar
to a traditional linear regression equation Y= α+ δXi + εi
where Y is the dependent variable, α is the intercept, δ
the coefficient on an explanatory variable (continuous
variable or dummy variable taking the value 1 for a posi-
tive outcome and 0 for a negative outcome for example)
and εi is the standard error. Thus, for the Nouna com-
munity based health insurance scheme, the household
net-benefit could be modeled as NBi = α+ δCBHIi + εi
where NBi is the net-benefit for each subject (or house-
hold), α is the intercept, CBHIi, is the intervention (tak-
ing the value zero if a household is not a member of the
scheme and 1 for a member), δti, is the incremental net
benefit and εi is the standard error. The interpretation is
straightforward and when this difference is greater than
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itional unit of effectiveness (in this case utilization of
health services) is below the Ro (the maximum the pro-
vider is willing to pay). The CBHI will be deemed cost-
effective in relation to the status quo. Similarly, if the
coefficient is negative, then the incremental cost for
one additional unit of effectiveness is above the Ro and
the status quo will be deemed cost-effective.
The basic model above (NBi = α+ δCBHIi + εi) could
then be expanded to include important covariates and
thereby allow the examination of the marginal impact of
these covariates on incremental cost effectiveness. The
final model may look like: NBi = α+
P
j=1
P βj xij + δti +P
j=1
P ýj xij + Ei where NBi is the summation of the inter-
action between the treatment dummy (Community
Based Health Insurance for example, coded yes or no)
and the covariates. ý’s magnitude and significance indi-
cates how the cost effectiveness of CBHI is expected to
vary at the margin. Thus the use of the net-benefit
model for presenting and interpreting cost-effectiveness
analysis results has the potential to overcome the double
dilemma of not being able to access progress using out-
comes measures (for example, computing maternal or
perinatal mortality) and not being able to reliably assess
cost-effectiveness using incremental cost-effectiveness
ratios. As indicated in the background section, cost ef-
fectiveness analysis traditionally relies on use of an in-
cremental cost effectiveness ratio (ICER) to indicate,
among a set of alternative strategies, which is the most
cost effective. Not only does the ICER as a ratio not in-
dicate what to do, how to do it or where to do it, the de-
cision rule is not straightforward when there is no clear
dominance of one alternative over another [2,6,14].
Moreover, there are very few situations in which deci-
sion makers decide to solely go with one strategy over
another. Rather, they are more likely to allocate
resources across a range of complementary strategies for
maximum health gains and thus the net-benefit frame-
work offers an advantage over the traditional ICER ap-
proach in presenting and interpreting results for public
health interventions (Table 1).
Ethical consideration
The study was approved by the ethical review board of
Nouna Health Research Centre.
Results
Descriptive analysis of the study populations
Table 2 describes the characteristics of the households
included in the Nouna panel household survey by enrol-
ment status in the Nouna CBHI scheme and by the
selected covariates (education, place, perceived quality of
care, asset ownership). The two groups are comparable
with respect to mean age of head of household (49.6 fornon-members versus 50.8 for households members, t-
test p = 0.148). There were significant differentials in en-
rolment in the Nouna CBHI scheme by utilization of
health services and by covariates. There was a 14 per-
centage point difference (85.4 - 71.4) in the utilization of
health services between members and non-members.
Similarly there were 20.6 (59.3 – 38.7), 23.1 (63.2 –
40.1), and 18.7 (34.3 – 15.6) percentage point differences
between members and non-members for people with at
least primary level of education, people living in Nouna
town, and assets ownership, respectively.
Standard cost-effectiveness analysis
In Table 3, the Incremental Cost Effectiveness Ratio
(ICER) was obtained by dividing the difference in aver-
age cost between the intervention and comparison
groups (70.253 – 9630) by the difference in average ef-
fect (utilization of health services) between the interven-
tion and comparison groups (0.85 – 0.71). The result is
equal to 433,000 XOF (approximately $1000) and is
interpreted as the overall incremental in cost for achiev-
ing one additional increase in household’s utilization of
health services (unit of effectiveness) for households
members in the community based insurance scheme
compared to household non-members. At this point the
Nouna CBHI scheme appears to be more costly and
more effective. The ICER estimates vary significantly by
covariates. For example, the incremental cost for one
extra institutional delivery within Nouna villages was
530,600 XOF (approximately $1250) compared to
301,700 XOF (approximately $700) in Nouna town. The
stratified ICER results (only place of residence reported
in this paper) confirm the existence of important sub-
groups and prompt interest in assessing how these cov-
ariates affect the overall cost-effectiveness of the
intervention.
Applying the net-benefit regression approach
Table 3 presents the results of the overall economic
evaluation with a range of arbitrary ceiling ratios (arbi-
trary but selected around the sample ICER). We use
place of residence (Nouna town versus Nouna villages)
as examples of covariates and present net-benefits esti-
mates for different values of the ceiling ratio (Ro) includ-
ing zero. The coefficients were obtained from an
Ordinary Least Squares (OLS) regression as explained
above and correspond to the increment net-benefit. The
aim of this analysis and the results displayed in this table
is to demonstrate that the standard descriptive analysis
for computing an Incremental Cost-Effectiveness Ratio
(ICER) is equivalent to the net-benefit framework, as the
linearization of the equation ICER= λ. One can verify
that when λ is = 0, the increment net-benefit (nb2 -
nb1) = λ*(Average effect1 – Average effect1) – (Average
Table 1 Relative advantages of net-benefit framework and incremental cost-effectiveness ratio for presenting and
interpreting results of cost-effectiveness analysis
Relative advantage criteria Standard Incremental Cost Effectiveness
Ratio (ICER)
Net Benefit Framework
Type of analysis Descriptive analysis, and stratified analysis
(by important covariates)
Regression analysis, and joint probability
distribution with important covariates
Confidence interval No Yes
Requirement of contextually
relevant threshold (ceiling ratio)
Yes, to assess if intervention is good
value for money
No, hypothetical ceiling ratios can be plotted




Variability explained by covariates No Yes
Relative advantages for interpretation Simple point estimate, greater or lower
than a ceiling ratio
Graphical presentation; illustration of alternative
scenarios with different ceiling ratios
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For example, when the ceiling value is 700,000 XOF
(equivalent to $1600) for example, the coefficients
obtained from the OLS regression for the overall sample,
populations in Nouna town, and populations in Nouna
villages are 37664 XOF, 77075 XOF, and 20354 XOF re-
spectively. It can be verified manually that these num-
bers correspond (apart from rounding errors) to what
would have been obtained by the equation (nb) = λ*
(effect) – (cost), where (nb) is the average net-benefit,
700,000 the ceiling ratio (λ), (effect) is the mean effect
and (cost) is the mean cost.Table 2 Descriptive characteristics of populations by
enrolment status (from household survey, 1504
household, 2007)
Characteristics Members Not members P-value
N (%) N (%)
Use of health services 0.000
- Did not use 53 (14.6) 281 (28.6)
- Have used 310 (85.4) 700 (71.4)
Education 0.000
- None 148 (40.7) 602 (61.3)
- At least primary school level 216 (59.3) 380 (38.7)
Place 0.000
- Nouna town 230 (63.2) 394 (40.1)
- Nouna villages 134 (36.8) 588 (59.9)
Asset ownership 0.000
- Most poor 3 (0.8) 235 (23.9)
- Second quartile 35 (9.6) 235 (23.9)
- Third quintile 85 (23.4) 198 (20.2)
- Fourth quintile 116 (31.9) 161 (16.4)
- Least poor 125 (34.3) 153 (15.6)
P-values are the level of significance on the Pearson chi-square test between
enrolment and covariates. There is no difference by age or sex between
members and not members.Table 4 presents the variations of the incremental net
benefit of the intervention with different ceiling ratios
and the probability of cost-effectiveness of Nouna CBHI
with different ceiling ratios. The probabilities that the
CBHI is cost-effective were computed and used to con-
struct the cost-effectiveness acceptability curve
(Figure 2).
Cost effectiveness acceptability curves
The cost-effectiveness acceptability curve graphically
represents the levels of certainty around the cost-
effectiveness analysis ratio of two interventions by plot-
ting hypothetical estimates of ceiling ratios against the
probability that a new intervention (the Nouna CBHI
scheme in our case) is preferred over an existing inter-
vention (the status quo). As can be seen on Figure 2 if
the decision makers in Nouna are only prepared to pay a
ceiling ratio less than 400,000 XOF ($920) the probabil-
ity that the Nouna CBHI scheme is preferred or deemed
cost effective is small less than 30%. However, if decision
makers in Nouna are willing to pay a ceiling ratio more
than 700,000 XOF ($1600) the probability that the
Nouna CBHI scheme is preferred or deemed cost effect-
ive increases to above 99% (asymptotic and close to but
never reaching 100%).
The same calculations and graphical representations
performed for the Nouna CBHI (Tables 4–5, Figure 2)
could be computed for subgroups of the sample by im-
portant covariates such as place of residence (dummy
variable coded 0 for Nouna villages and 1 for Nouna
town) or education (dummy variable coded 0 for no
education and 1 for some education). The results are
presented in Table 6 and Figures 3. Overall, lower ceiling
ratios are needed to achieve a given probabilities that
the Nouna CBHI is cost-effective in Nouna town versus
Nouna villages. In the communities of Nouna villages,
the probability that the Nouna CBHI scheme is cost-
effective is close to zero when the decision makers in
Nouna are only prepared to pay less than 300,000 XOF
Table 3 Sample statistics from the economic evaluation of the Nouna CBHI, data with net-benefit, household survey,
2007, Nouna districts Burkina Faso
Group variables Mean SD SE
Overall analysis
Comparison group
(Not members N= 982 )
Cost 9630 0.000 0.000
Effect (%) 71 0.452 0.014
Intervention group
(Members N = 364)
Cost 70253 11658 611
Effect (%) 85 0.125 0.019
Increments
Cost difference* 60623 - 372




Cost difference 64207 - 545
(%) Effect difference 12.1 - 0.039
Sample ICER 5306
Nouna town group
Cost difference 58535.5 - 507
(%) Effect difference 19.4 - 0.036
Sample ICER 3017
Incremental net-benefit Coefficient (SE)
Values of ceiling ratio (R) Overall Nouna town Nouna villages
R = 0 - 60623 (193) - 58535.5 (507) - 64207 (545)
R = 500 000 9577 (13143) 38324 (18335) - 3806 (19683)
R = 700 000 28034 (18400) 77075 (25667) 20354 (27543)
R = 1 000 000 70165 (26286) 135203 (36692) 56594 (39335)
ICER = Cost of having one additional% of utilization of health service among members.
* Equal variance not assumed. The costs are in CFA, West Africa French currency.
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approaches 100% above a ceiling ratio of 1,500,000 XOF
($3460. However, in Nouna town the probability that the
Nouna CBHI scheme is cost-effective is nearly 50% at
the ceiling ratio of 300,000 ($690) for one extra use of
health services and approaches 100% at a ceiling ratio
about 500,000 XOF ($1150).
We could then assess, as for any regression analysis,
the effect of covariates on the cost-effectiveness, the
interaction between covariates, any collinearity or resi-
duals. The full results are not presented here as the goal
is primarily to demonstrate the applicability of the net-
benefit framework to observational public health studies
rather than the robustness of the results or any model.
We present in Table 7 and on Figure 4 covariatesadjusted net-benefit regression estimates with different
ceiling ratios, adjusted (to place of residence) and un-
adjusted cost-effectiveness acceptability curves of the
Nouna CBHI respectively. It can be observed in Figure 4
that when adjusted to place (Nouna town versus Nouna
villages), the ceiling ratio that corresponds to a 50%
probability that the intervention is cost-effective (ICER)
is significantly lower than the ICER computed. This is
critically important and indicates the importance of
adjusting the cost-effectiveness results to known signifi-
cant covariates. Also, the probability that the Nouna
CBHI scheme is cost-effective is higher at any ceiling
ratio lower than or equals to 800,000 XOF ($1850) when
the net-benefits are adjusted to place of residence
(Nouna town versus Nouna villages). This result
Table 4 Simple net-benefit regression estimates with different ceiling ratios, Nouna community based health
insurance, household survey, 2007, Burkina Faso
N=1344 NMB With NMB With NMB With NMB With NMB With NMB With
λ =0a λ =500000 λ =700000 λ =1000000 λ =1500000 λ =2000000
Explanatory [SE] (p-value) [SE] (p-value) [SE] (p-value) [SE] (p-value) [SE] (p-value) [SE] (p-value)
Variables
Constant term 9630 347148 489860 703927 1060706 1417485
[193] (1.000) [6830] (0.000) [9562] (0.000) [13660] (0.000) [193] (0.000) [193] (0.000)
220232
Intervention strategy (CBHI) - 60623 9577 37664 79795 150013 [372] (0.000)
[372] (0.000) [13143] (0.466) [18400] (0.041) [26286] (0.002) [372] (0.000)
R2 (adjusted) 0.952 0.000 0.003 0.007 0.011 0.013
F (1, 1344) 26587 0.531 4.2 9.2 14.4 17.5
Prob > F < 0.000 < 0.000 < 0.000 < 0.000 < 0.000 < 0.000
a When λ =0, NMB=− Cost. The values of λ= are in CFA, West Africa French currency.
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cost-effective is very high in Nouna town compared to
Nouna villages if decision makers in Nouna are willing
to pay a ceiling ratio lower than 800,000 XOF ($1850).
This important result is more informative than the
stratified analysis of the ICER and would not have been
possible without a joint probability distribution of the
intervention effects and covariates, hence the import-
ance of the net-benefit approach in identifying the
effects of important covariates on the cost-effectiveness
results.
Discussion
With the traditional ICER, we concluded that approxi-
mately $1000 was the incremental in cost for achieving
one additional increase in utilization of health services
in the intervention area. However, there was noTable 5 Cost-effectiveness acceptability curves from the net-b
Burkina Faso
Values of ceiling ratio Treatment (intervention) coefficients On
Estimates P-values
0 - 60623 0 0
400 000 - 4466 0.671 0.3
500 000 9577 0.466 0.2
600 000 23620 0.134 0.0
700 000 37664 0.041 0.0
800 000 51708 0.014 0.0
900 000 65751 0.006 0.0
1 000 000 79795 0.002 0.0
1 500 000 150013 < 0.000 < 0
2 000 000 220232 < 0.000 < 0
2 500 000 290450 < 0.000 < 0
The values of ceiling ratio are in CFA, West Africa French currency.context specific threshold (ceiling ratio) to indicate if
the $1,000 was a good value for money for achieving
one households’ extra utilization of health services.
This estimate provides no clue for what to do, how to
do it or where to do it if one is concerned with equity
issues in universal health coverage. What could be
more helpful is to have some insights in how the cost-
effectiveness vary by some equity determinants (for ex-
ample covering Nouna villages or Nouna town, or design
the intervention by groups of households’ assets own-
ership) which will be the basis for policy making. By
applying the net-benefit framework, we were able to
conclude that the probability (adjusting for place) of
the Nouna community based health insurance to
achieve one extra utilization of health services when
the ceiling ratio is approximately $1,000 is barely 30%
for Nouna villages whilst the corresponding probabilityenefit regression, Nouna CBHI, household survey, 2007,













Table 6 Cost-effectiveness acceptability curves, net-benefit OLS regression, Nouna CBHI (Place covariate)















Estimates P-values % Estimates P-values %
0 - 58535 0 0 0 - 64207 0 0 0
200 000 −19803 0.007 0.003 0.3 - 40046 0 0 0
300 000 - 427 0.969 0.484 48.4 - 27966 0.018 0.009 0.9
400 000 18948 0.197 0.098 90.2 - 15886 0.314 0.157 15.7
500 000 38324 0.037 0.018 98.2 −3806 0.847 0.423 42.3
600 000 57700 0.009 0.004 99.6 8274 0.726 0.363 63.7
700 000 77075 0.003 0.001 99.9 20353 0.460 0.230 77
800 000 96451 0.001 0.000 99.99 32434 0.303 0.151 84.9
900 000 115827 0.000 0.000 99.99 44514 0.209 0.104 89.6
1 000 000 135203 0.000 0.000 99.99 56594 0.151 0.075 92.5
1 500 000 232081 0.000 0.000 99.99 116995 0.048 0.024 97.6
2 000 000 328960 0.000 0.000 99.99 177395 0.024 0.012 98.8
2 500 000 425840 0.000 0.000 99.99 237796 0.016 0.008 99.2
The values of ceiling ratio are in CFA, West Africa French currency.
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piece of information has important implication for pol-
icy making if decision makers are concerned with
achieving high probability of cost-effectiveness of the
intervention in the poorest population (Nouna villages)
and would not have been possible just by using strati-
fied analysis on the traditional ICER approach. As
pointed by Hosh JS [3] the existence of important
sub-groups affects how the cost-effectiveness varies at
the margin and need to be accounted for when analyz-
ing and interpreting cost-effectiveness results. This is



































Figure 3 Unadjusted cost-effectiveness acceptability curves, Nouna C
on X-axis actual values correspond to displayed values * 1000.Identifying what intervention is cost-effective com-
pared to an alternative is an important piece of informa-
tion, and we have now seen that even if one does not
know the true value of the ceiling ratio, using a cost-
effectiveness acceptability curve (Figure 2) it is possible
to show the level of uncertainty surrounding the esti-
mated ICER. Computing the ICER point estimate (as-
suming we know the context specific ceiling ratio to rule
if a good value for money) does not provide clues about
what policy makers could do, how to do it or where to
do it when there are important subgroups. Although it is





BHI overall and with covariate place, Burkina Faso. * Please note
Table 7 Simple net-benefit regression estimates with different ceiling ratios, and covariates adjusted net-benefit
regression estimates, Nouna community based health insurance, household survey, 2007, Burkina Faso
N=1344 NMB With NMB With NMB With NMB With NMB With NMB With
λ =0a λ =500000 λ =700000 λ =1000000 λ =1500000 λ =2000000
Explanatory [SE] (p-value) [SE] (p-value) [SE] (p-value) [SE] (p-value) [SE] (p-value) [SE] (p-value)
Variables
Constant term −8595 317202 447519 642993 968784 1294575
[394] (0.000) [14159] (0.000) [19820] (0.000) [28311] (0.00) [42466] (0.000) [56620] (0.000)
Covariates
Education 1700 44652 61835 87609 130565 173522
[335] (0.000) [12017] (0.000) [16821] (0.000) [24028] (0.000) [36040] (0.000) [48053] (0.000)
Place of residence 2255 - 67742 - 95741 - 137739 - 207735 −277731
[358] (0.000) [12864] (0.000) [18007] (0.000) [25772] (0.000) [38582] (0.000) [51443] (0.000)
Asset ownership - 942 14455 20614 29853 45252 60651
[136] (0.000) [4879] (0.003) [6830] (0.003) [9756] (0.002) [14633] (0.002) [19511] (0.002)
Intervention (CBHI) - 60425 - 10044 23594 59608 119630 179652
[390] (0.000) [13995] (0.473) [19990] (0.229) [27983] (0.033) [41973] (0.004) [55963] (0.001)
R2 (adjusted)
F (4 1343) 0.955 0.031 0.034 0.037 0.041 0.043
Prob> F 7077 10.6 11.6 12.9 14.4 15.2
0.000 0.000 0.000 0.000 0.000 0.000
a When λ =0, NMB=− Cost. The values of ceiling ratio are in CFA, West Africa French currency.
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http://www.resource-allocation.com/content/10/1/8appropriate weighting [16] to assess how the covariates
affect the cost-effectiveness at the margin, modeling will
rely on data from secondary sources, instead of actual
household level effect and cost data.
If the decision makers are concerned with meeting the
needs of the poorest and equity [9,17,18] we argue we
need a joint probability distribution of context specific
data on cost and effect and the intervention withFigure 4 Adjusted (to place of residence) and unadjusted cost-effecti
Please note on X-axis actual values correspond to displayed values * 1000.important determinants of poverty so that policy making
be based on the most important determinants (adjusting
to known covariates). For example, when examining the
net-benefit regression results (Table 7) it can be noted
that only a small fraction (3.4%) of the variability in
cost-effectiveness can be explained by covariates used in
the analysis. This is very small and points to the exist-
ence of unknown important variables not captured inveness acceptability curves, Nouna CBHI, 2007, Burkina Faso. *
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http://www.resource-allocation.com/content/10/1/8our analysis or the low content validity of our con-
structed metrics. In any case, this type of information is
very useful for appraising the likelihood of covariates to
affect the cost-effectiveness of the intervention. Al-
though decision making does not revolve around cost-
effectiveness analysis results, this type of information
may be very useful for policy making and is not possible
to have with the more traditional ICER approach. This is
the main potential of the net-benefit framework when
applying to public health interventions such as universal
health coverage.
Lastly, while the main concern of this paper is with
methodological challenges, the high values of the ceiling
ratios that we found for the CHBI scheme to be cost-
effective are of interest. Together with other evidence,
such as the lack of any significant reduction in mortal-
ity rates, the low enrolment rates [9,10], and the high
costs of the scheme [12] cast great doubt upon its cost-
effectiveness. Our findings thus challenge the currently
fashionable assumption that community based health
insurance schemes are a very promising way to extend
access to health care in low and middle income
countries.
From a methodological point of view, the net –benefit
approach opens up the possibility of a marriage of epi-
demiological, demographic and econometric analytical
frameworks in appraising the monetary values of public
health interventions. Its application requires the avail-
ability of person-level or household-level effect and cost
data collection, which in turn will require change to
current well established tools and methods of national
or sub national household surveys. Although this work
was focused on using some of the properties of regres-
sion techniques for utilization of health services, there is
a possibility, with increasing emphasis on valuing health
outcomes in the developing world, to actually use the
full potential of regression frameworks and predict for
example the net-gains of interventions in saving the lives
of women and newborns.. Given this paper is mainly to
demonstrate feasibility and applicability of the net-
benefit approach and data implications we did not ex-
tend on other model diagnosis tests such as normality of
residuals.
Conclusions
There are some challenges in interpreting the traditional
ICER results. Regardless of the accuracy of the costing
methodology, there remain issues about the level of cer-
tainty of the computed estimate. The decision rule of
the ICER estimate requires knowledge as to whether the
estimate is below or above an externally set value which
is the maximum decision makers will be willing to pay
for an extra unit of health gain. This value is unknown
in most cases but in these circumstances, the net-benefitapproach has proven feasible and more insightful in
assessing cost-effectiveness of a public health interven-
tion aiming at universal health coverage. The net-benefit
approach has the relative advantages of better presenta-
tion and interpretation of cost-effectiveness analysis
results. The most important advantage in our view is the
possible information on the marginal cost-effectiveness
of important covariates particularly when decision
makers are concerned with important determinants or
equity as is often the case in public health interventions.
However, its applicability requires appropriate data sets
(household-level effect and cost data) which will require
that we revise the traditional methods and tools of
household surveys to ensure concurrent collection of
household-level effect and cost data.
Competing interests
The authors declare that they have no competing interests
Authors’ contribution
SH conceived the study (as part of his doctoral thesis), led the data
collection, constructed the database, performed the statistical analysis and
drafted the manuscript. David Newlands participated in the design of the
study, data collection and data analysis. All authors read and approved the
final manuscript.
Authors’ information
Sennen Hounton is a medical epidemiologist with expertise in maternal and
newborn health, health systems and economic evaluation. Sennen Hounton
has an MD (Benin), MPH in Epidemiology (University of Oklahoma, USA) and
a PhD in Public Health from University of Aberdeen, (Scotland, UK). He was a
Senior Research Fellow with Immpact (Initiative for Maternal Mortality
Program Assessment). He is currently Maternal Health Technical Adviser at
the United Nations Population Fund (New–York), and served as Scientific and
Technical Advisor on the WHO Alliance for Health Policy and System
Research Scientific and Technical Advisory Committee.
David Newlands is a Senior Lecturer in Economics, previously Team Leader
of the Economic Outcomes of an international research programme –
Immpact. He is currently a Senior Lecturer at the Business School of
University of Aberdeen, Scotland, UK.
Acknowledgements
This work was undertaken as part of Dr Sennen Hounton’s doctoral
programme, funded by the international research programme – Immpact,
University of Aberdeen. A special thanks to Wendy J Graham, Nicolas Meda,
Peter Byass, and Bocar Kouyate. The funders have no responsibility for the
information provided or views expressed in this paper. The views expressed
herein are solely those of the authors.
Author details
1Department of Epidemiology, Centre MURAZ, 2054 Avenue Mamadou
KONATE, Bobo-Dioulasso 01 BP 390, Burkina Faso. 2Business School,
University of Aberdeen, Edward Wright Building, Dunbar Street, Old
Aberdeen AB24 3QY, Scotland, United Kingdom.
Received: 22 December 2011 Accepted: 28 June 2012
Published: 16 July 2012
References
1. Drummond MF, Sclpher MJ, Torrance GW, O’Brien BJ, Stoddart GL: Methods
for the economic evaluation of health care programmes. New-York: Oxford
University Press; 2005.
2. Hoch JS, Briggs AH, William AR: Something old, something new,
something borrowed, something blue: a framework for the marriage of
health econometrics and cost-effectiveness analysis. Health Econ 2002,
11:415–430.
Hounton and Newlands Cost Effectiveness and Resource Allocation 2012, 10:8 Page 11 of 11
http://www.resource-allocation.com/content/10/1/83. Hoch JS, Rockx MA, Krahn AD: Using net-benefit regression framework to
construct cost-effectiveness acceptability curves: an example using data
from a trial of external loop recorders versus Holter monitoring for
ambulatory monitoring of “community acquired” syncope. BMC Health
Serv Res 2006, 6:68.
4. Hoch JS, Dewa CS: Lessons from trial-based cost-effectiveness analysis of
mental health interventions. Why uncertainty about outcomes, estimates
and willingness-to-pay matters. Pharmacoecnomics 2007, 25(10):807–816.
5. Hoch JS, Blume JD: Measuring and illustrating statistical evidence in a
cost-effectiveness analysis. J Health Econ 2008, 27:476–495.
6. Claxton K: The irrelevance of inference: a decision making framework to
the stochastic evaluation of health care technologies. J Health Econom
1999, 18:341–364.
7. Briggs A, Fenn P: Confidence intervals or surfaces? Uncertainty of the
cost-effectiveness plane. Health Econ 1998, 7:723–740.
8. Briggs AH, Gray AM: Handling uncertainty when performing economic
evaluation of healthcare interventions. Health Technol Assess 1999,
3(2):1–134.
9. Dong H, De Allegri M, Gnawali D, Souares A, Sauerborn R: Drop-out
analysis of community-based health insurance membership at Nouna,
Burkina Faso. Health Policy 2009, 92(2–3):174–179.
10. Dong H, Gbangou A, De Allegri M, Pokhrel S, Sauerborn R: The differences
in characteristics between health-care users and non-users: implication
for introducing community-based health insurance in Burkina Faso. Eur J
Health Econ 2008, 9(1):41–50.
11. Dong H, Kouyate B, Cairns J, Mugisha F, Sauerborn R: Willingness-to-pay
for community-based insurance in Burkina Faso. Health Econ 2003,
12(10):849–862.
12. Dong H, Kouyate B, Cairns J, Sauerborn R: Differential willingness of
household heads to pay community-based health insurance premia for
themselves and other household members. Health Policy Plan 2004,
19(2):120–126.
13. De Allegri M, Sauerborn R: Community based health insurance in
developing countries. BMJ 2007, 334(7607):1282–1283.
14. Lothgren M, Zethraeus N: Definitions, interpretation and calculation of
cost effectiveness acceptability curves. Health Econ 2000, 9:623–630.
15. Van Hout VA, Al MJ, Gordon GS, Rutten FF: Costs, effects and C/E ratios
alongside a clinical trial. Health Econ 1994, 3:309–319.
16. Schroeder E, Petrou S, Patel N, Hollowell J, Puddicombe D, Redshaw M,
Brocklehurst P, Birthplace in England Collaborative Group: Cost
effectiveness of alternative planned places of birth in woman at low risk
of complications: evidence from the Birthplace in England national
prospective cohort study. BMJ 2012, 344:e2292.
17. Ranson MK, Sinha T, Chatterjee M, Gandhi F, Jayswal R, Patel F, Morris SS,
Mills AJ: Equitable utilisation of Indian community based health
insurance schemes among its rural membership: cluster randomised
controlled trial. BMJ 2007, 334(7607):1309.
18. Chowdhury ME, Ronsmans C, Killewo J, Anwar I, Gausia K, Das-Gupta S,
Blum LS, Dieltiens G, Marshall T, Saha S, Borghi J: Equity in use of home-
based or facility-based skilled obstetric care in rural Bangladesh: an
observational study. Lancet 2006, 367(9507):327–332.
doi:10.1186/1478-7547-10-8
Cite this article as: Hounton and Newlands: Applying the net-benefit
framework for assessing cost-effectiveness of interventions towards
universal health coverage. Cost Effectiveness and Resource Allocation 2012
10:8.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
